Advertisement

Approach to Diagnosis: Echocardiography

  • Beevash Ray
  • Matthew W. Martinez
Chapter

Abstract

The diagnosis of HCM can be challenging. Echocardiography has become the primary method for the initial evaluation of patients with suspected hypertrophic cardiomyopathy. The integrated utilization of two-dimensional echocardiography, doppler echocardiography, and stress echocardiography allows for the evaluation of the presence and severity of LV wall thickness, diastolic dysfunction, LVOT obstruction and mitral regurgitation. Thus, echocardiography offers the clinician a comprehensive imaging modality in those with suspected HCM, those previously diagnosed, and those undergoing surveillance or therapeutic intervention. In this chapter, we detail the benefits of echocardiography for the diagnosis, monitoring, and management of those with suspected or known HCM.

Keywords

Hypertrophic Cardiomyopathy Systolic anterior motion of the mitral valve Two-Dimensional Echocardiography Doppler Echocardiography Stress Echocardiography 

References

  1. 1.
    Adelman AG, McLoughlin MJ, Marquis Y, et al. Left ventricular cineangiographic observations in muscular subaortic stenosis. Am J Cardiol. 1969;24:689–97.PubMedCrossRefGoogle Scholar
  2. 2.
    Braunwald E, Lambrew CT, Rockoff SD, et al. Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation. 1964;30 Suppl 4:3–119.PubMedGoogle Scholar
  3. 3.
    Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol. 1981;48:418–28.PubMedCrossRefGoogle Scholar
  4. 4.
    Geske JB, Sorajja P, Nishimura RA, Ommen SR. Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation. 2007;116:2702–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Yang H, Sun JP, Lever HM, Popovic ZB, Drinko JK, Greenberg NL, et al. Use of strain imaging in detecting segmental dysfunction in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2003;16:233–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42:1687–713.PubMedCrossRefGoogle Scholar
  7. 7.
    Feigenbaum H, Armstrong WF, Ryan T, Feigenbaum H. Feigenbaum’s echocardiography. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 139. Print.Google Scholar
  8. 8.
    Oh JK, Seward JB, Jamil Tajik A. The echo manual. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 22. Print.Google Scholar
  9. 9.
    Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB. Contemporary definitions and classification of the cardiomyopathies. Circulation. 2006;113:1807–16.PubMedCrossRefGoogle Scholar
  10. 10.
    Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2761–96.PubMedCrossRefGoogle Scholar
  11. 11.
    Harvey F, Armstrong WF, Ryan T, Feigenbaum H. Feigenbaum’s echocardiography. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 181. Print.Google Scholar
  12. 12.
    Nistri S, Olivotto I, Betocchi S, Losi MA, Valsecchi G, Pinamonti B, Conte MR, Casazza F, Galderisi M, Maron BJ, Cecchi F. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol. 2006;98:960–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Wigle ED, Sasson Z, Henderson MA, et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis. 1985;28:1–83.PubMedCrossRefGoogle Scholar
  14. 14.
    Maron BJ, Epstein SE. Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet. Am J Cardiol. 1980;45:141–54.PubMedCrossRefGoogle Scholar
  15. 15.
    Williams LK, Frenneaux MP, Steeds RP. Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management. Eur J Echocardiogr. 2009;10:iii9–14.PubMedCrossRefGoogle Scholar
  16. 16.
    Wigle ED, Sasson Z, Henderson MA, et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis. 1985;28:1–83.PubMedCrossRefGoogle Scholar
  17. 17.
    Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2761–96.PubMedCrossRefGoogle Scholar
  18. 18.
    Basavarajaiah S, Wilson M, Whyte G, Shah A, McKenna W, Sharma S. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. J Am Coll Cardiol. 2008;51:1033–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol. 1995;26:1699–708.PubMedCrossRefGoogle Scholar
  20. 20.
    Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1990;15:1521–6. 20.PubMedCrossRefGoogle Scholar
  21. 21.
    Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342:1778–85.PubMedCrossRefGoogle Scholar
  22. 22.
    Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, Weil J, Zenovich AG, Maron BJ. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005;112:855–61.PubMedCrossRefGoogle Scholar
  23. 23.
    Martinez MW. Mid-cavitary obstruction in hypertrophic cardiomyopathy. Heart. 2008;94(10):1287.PubMedCrossRefGoogle Scholar
  24. 24.
    Monserrat L, Hermida-Prieto M, Fernandez X, Rodríguez I, Dumont C, Cazón L, Cuesta MG, Gonzalez-Juanatey C, Peteiro J, Alvarez N, Penas-Lado M, Castro-Beiras A. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur Heart J. 2007;28:1953–61.PubMedCrossRefGoogle Scholar
  25. 25.
    McKenna WJ, Kleinebenne A, Nihoyannopoulos P, Foale R. Echocardiographic measurement of right ventricular wall thickness in hypertrophic cardiomyopathy: relation to clinical and prognostic features. J Am Coll Cardiol. 1988;1:351–8.CrossRefGoogle Scholar
  26. 26.
    Maron MS, Hauser TH, Dubrow E, Horst TA, Kissinger KV, Udelson JE, Manning WJ. Right ventricular involvement in hypertrophic cardiomyopathy. Am J Cardiol. 2007;100:1293–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358–67.PubMedCrossRefGoogle Scholar
  28. 28.
    Maron BJ, Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol. 1998;81:1339–44.PubMedCrossRefGoogle Scholar
  29. 29.
    Olivotto I, Girolami F, Nistri S, Rossi A, Rega L, Garbini F, Grifoni C, Cecchi F, Yacoub MH. The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice. J Cardiovasc Transl Res. 2009;2:349–67.PubMedCrossRefGoogle Scholar
  30. 30.
    Maron BJ, Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol. 1998;81:1339–44.PubMedCrossRefGoogle Scholar
  31. 31.
    Fujiwara H, Onodera T, Tanaka M, Shirane H, Kato H, Yoshikawa J, Osakada G, Sasayama S, Kawai C. Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage. Jpn Circ J. 1984;48:1210–4.PubMedCrossRefGoogle Scholar
  32. 32.
    Harris KM, Spirito P, Maron MS, et al. Prevalence, clinical profile, and signifi cance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation. 2006;114:216–25.PubMedCrossRefGoogle Scholar
  33. 33.
    Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR, Picard MH, Polk DM, Ragosta M, Ward RP, Weiner RB. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 appropriate use criteria for echocardiography: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Endorsed by the American College of Chest Physicians. J Am Coll Cardiol. 2011;57:1126–66.PubMedCrossRefGoogle Scholar
  34. 34.
    Feigenbaum H, Armstrong WF, Ryan T, Feigenbaum H. Feigenbaum’s echocardiography. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 184. Print.Google Scholar
  35. 35.
    Sachdev V, Shizukuda Y, Brenneman CL, Birdsall CW, Waclawiw MA, Arai AE, Mohiddin SA, Tripodi D, Fananapazir L, Plehn JF. Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy. Am Heart J. 2005;149(4):730–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Yang H, et al. Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr. 2005;18(10):1074–82.PubMedCrossRefGoogle Scholar
  37. 37.
    Hatle L, Angelsen B. Doppler ultrasound in cardiology. 2nd ed. Philadelphia: Lea & Febiger; 1985.Google Scholar
  38. 38.
    Izgi C, Akgun T, Men EE, Feray H. Systolic anterior motion of the mitral valve in the absence left ventricular hypertrophy: role of mitral leaflet elongation and papillary muscle displacement. Echocardiography. 2010; 27:E36–8.Google Scholar
  39. 39.
    Lefebvre XP, He S, Levine RA, Yoganathan AP. Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: an in vitro pulsatile flow study. J Heart Valve Dis. 1995;4:422–38.Google Scholar
  40. 40.
    He S, Hopmeyer J, Lefebvre XP, Schwammenthal E, Yoganathan AP, Levine RA. Importance of leaflet elongation in causing systolic anterior motion of the mitral valve. J Heart Valve Dis. 1997;6:149–59.PubMedGoogle Scholar
  41. 41.
    Sherrid MV, Gunsburg DZ, Moldenhauer S, Pearle G. Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2000;36:1344–54.PubMedCrossRefGoogle Scholar
  42. 42.
    Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Klues HG, Roberts WC, Maron BJ. Morphological determinants of echocardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy. Circulation. 1993;87:1570–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Hoigne P, Attenhofer Jost CH, Duru F, Oechslin EN, Seifert B, Widmer U, et al. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy. Int J Cardiol. 2006;111:413–22.PubMedCrossRefGoogle Scholar
  45. 45.
    Yu EH, Omran AS, Wigle ED, Williams WG, Siu SC, Rakowski H. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiol. 2000;36:2219–25.PubMedCrossRefGoogle Scholar
  46. 46.
    Kaple RK, Murphy RT, DiPaola LM, Houghtaling PL, Lever HM, Lytle BW, et al. Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Ann Thorac Surg. 2008;85:1527–35. 1535.PubMedCrossRefGoogle Scholar
  47. 47.
    Omoto R, Kasai C. Physics and instrumentation of Doppler color flow mapping. Echocardiography. 1987;4:467–83.CrossRefGoogle Scholar
  48. 48.
    Yu EH, Omran AS, Wigle ED, Williams WG, Siu SC, Rakowski H. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiol. 2000;36:2219–25.PubMedCrossRefGoogle Scholar
  49. 49.
    Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation. 2008;118:1541–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Oh JK, Seward JB, Jamil Tajik A. The echo manual. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 60. Print.Google Scholar
  51. 51.
    Maron BJ, Gottdiener JS, Arce J, et al. Dynamic subaortic obstruction in hypertrophic cardiomyopathy: analysis by pulsed Doppler echocardiography. J Am Coll Cardiol. 1985;6:1–18.PubMedCrossRefGoogle Scholar
  52. 52.
    Hatle L, Angelsen B. Doppler ultrasound in cardiology. 2nd ed. Philadelphia: Lea & Febiger; 1985.Google Scholar
  53. 53.
    Bom K, de Boo J, Rijsterborgh H. On the aliasing problem in pulsed Doppler cardiac studies. J Clin Ultrasound. 1984;12:559–67.PubMedCrossRefGoogle Scholar
  54. 54.
    Panza JA, Petrone RK, Fananapazir L, Maron BJ. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1992;19(1):91–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outfl ow tract obstruction. Circulation. 2006;114:2232–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Shah JS, Esteban MT, Thaman R, Sharma R, Mist B, Pantazis A, Ward D, Kohli SK, Page SP, Demetrescu C, Sevdalis E, Keren A, Pellerin D, McKenna WJ, Elliott PM. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart. 2008;94:1288–94.PubMedCrossRefGoogle Scholar
  57. 57.
    Briguori C, Betocchi S, Losi MA, et al. Noninvasive evaluation of left ventricular diastolic function in hypertrophic cardiomyopathy. Am J Cardiol. 1998;81:180–7.PubMedCrossRefGoogle Scholar
  58. 58.
    Maron BJ, Spirito P, Green KJ, Wesley YE, Bonow RO, Arce J. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1987;10:733–42.PubMedCrossRefGoogle Scholar
  59. 59.
    Nishimura RA, Appleton CP, Redfield MM, Ilstrup DM, Holmes Jr DR, Tajik AJ. Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol. 1996;28:1226–33.PubMedCrossRefGoogle Scholar
  60. 60.
    Geske JB, Sorajja P, Nishimura RA, Ommen SR. Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation. 2007;116:2702–8.PubMedCrossRefGoogle Scholar
  61. 61.
    Matsumura Y, Elliott PM, Virdee MS, Sorajja P, Doi Y, McKenna WJ. Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity. Heart. 2002;87:247–51.PubMedCentralPubMedCrossRefGoogle Scholar
  62. 62.
    McMahon CJ, Nagueh SF, Pignatelli RH, et al. Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy. Circulation. 2004;109:1756–62.PubMedCrossRefGoogle Scholar
  63. 63.
    Ho CY, Solomon SD. A clinician’s guide to tissue Doppler imaging. Circulation. 2006;113:e396–8.PubMedCrossRefGoogle Scholar
  64. 64.
    Vinereanu D, Florescu N, Sculthorpe N, Tweddel AC, Stephens MR, Fraser AG. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol. 2001;88:53–8.PubMedCrossRefGoogle Scholar
  65. 65.
    Bayrak F, Kahveci G, Mutlu B, Sonmez K, Degertekin M. Tissue Doppler imaging to predict clinical course of patients with hypertrophic cardiomyopathy. Eur J Echocardiogr. 2008;9:278–83.PubMedCrossRefGoogle Scholar
  66. 66.
    Yang H, Sun JP, Lever HM, Popovic ZB, Drinko JK, Greenberg NL, et al. Use of strain imaging in detecting segmental dysfunction in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2003;16:233–9.PubMedCrossRefGoogle Scholar
  67. 67.
    Carasso S, Yang H, Woo A, Vannan MA, Jamorski M, Wigle ED, et al. Systolic myocardial mechanics in hypertrophic cardiomyopathy: novel concepts and implications for clinical status. J Am Soc Echocardiogr. 2008;21:675–83.PubMedCrossRefGoogle Scholar
  68. 68.
    Van Dalen BM, Kauer F, Soliman OI, Vletter WB, Michels M, ten Cate FJ, et al. Influence of the pattern of hypertrophy on left ventricular twist in hypertrophic cardiomyopathy. Heart. 2009;95:657–61.PubMedCrossRefGoogle Scholar
  69. 69.
    Popovic ZB, Kwon DH, Mishra M, et al. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. J Am Soc Echocardiogr. 2008;21:1299–305.PubMedCrossRefGoogle Scholar
  70. 70.
    Nishimura RA, Ommen SR. Hypertrophic cardiomyopathy: the search for obstruction. Circulation. 2006;114:2200–2.PubMedCrossRefGoogle Scholar
  71. 71.
    Okeie K, Shimizu M, Yoshio H, Ino H, Yamaguchi M, Matsuyama T, Mabuchi H. Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2000;36(3):856–63.PubMedCrossRefGoogle Scholar
  72. 72.
    Pellikka PA, Oh JK, Bailey KR, Nichols BA, Monahan KH, Tajik AJ. Dynamic intraventricular obstruction during dobutamine stress echocardiography. A new observation. Circulation. 1992;86(5):1429–32.PubMedCrossRefGoogle Scholar
  73. 73.
    Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2011;142:1303–8.PubMedCrossRefGoogle Scholar
  74. 74.
    Kawano S, Iida K, Fujieda K, Yukisada K, Magdi ES, Iwasaki Y, Sugishita Y. Response to isoproterenol as a prognostic indicator of evolution from hypertrophic cardiomyopathy to a phase resembling dilated cardiomyopathy. J Am Coll Cardiol. 1995;25(3):687–92.PubMedCrossRefGoogle Scholar
  75. 75.
    Marwick TH, Nakatani S, Haluska B, Thomas JD, Lever HM. Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy. Am J Cardiol. 1995;75(12):805–9.PubMedCrossRefGoogle Scholar
  76. 76.
    Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232–9.PubMedCrossRefGoogle Scholar
  77. 77.
    Schwammenthal E, Schwartzkopff B, Block M, Johns J, Lösse B, Engberding R, Breithardt G. Doppler echocardiographic assessment of the pressure gradient during bicycle ergometry in hypertrophic cardiomyopathy. Am J Cardiol. 1992;69(19):1623–8.PubMedCrossRefGoogle Scholar
  78. 78.
    Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2011;142:1303–8.PubMedCrossRefGoogle Scholar
  79. 79.
    Argulian E, Chaudhry FA. Stress testing in patients with hypertrophic cardiomyopathy. Prog Cardiovasc Dis. 2012;54:477–82.PubMedCrossRefGoogle Scholar
  80. 80.
    Nagueh SF, Lakkis NM, He ZX, Middleton KJ, Killip D, Zoghbi WA, Quiñones MA, Roberts R, Verani MS, Kleiman NS, Spencer III WH. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1998;32:225–9.PubMedCrossRefGoogle Scholar
  81. 81.
    Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211–4.PubMedCrossRefGoogle Scholar
  82. 82.
    Alam M, Dokainish H, Lakkis N. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies. J Interv Cardiol. 2006;19:319–27.PubMedCrossRefGoogle Scholar
  83. 83.
    Teis A, Sheppard MN, Alpendurada F. Subaortic membrane: correlation of imaging with pathology. Eur Heart J. 2010;31:2822.PubMedCrossRefGoogle Scholar
  84. 84.
    Rahman JE, Helou EF, Gelzer-Bell R, Thompson RE, Kuo C, Rodriguez ER, et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol. 2004;43(3):410–5.PubMedCrossRefGoogle Scholar
  85. 85.
    Badano L, Fox K, Sicari R, Zamorano JL. Disease with a main influence on myocardial tissue damage. In: EAE textbook of echocardiography. 1st ed. Oxford (UK): Oxford Medical Press; 2011. p. 335–6.Google Scholar
  86. 86.
    Phelan D, Collier P, Thavendiranathan P, Popovic ZB, Hanna M, Plana JC, et al. Relative ‘apical sparing’ of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98(19):1442–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2015

Authors and Affiliations

  1. 1.Division of Cardiology, Department of MedicineWinthrop University HospitalMineolaUSA
  2. 2.Sports Cardiology and Hypertrophic Cardiomyopathy Program, Division of Cardiology, Department of MedicineLehigh Valley Health NetworkAllentownUSA

Personalised recommendations